Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$134.00

-6.09 (-4.35%)

12:55
07/12/19
07/12
12:55
07/12/19
12:55

J&J tells Reuters implication of new development is 'flatly wrong'

Johnson & Johnson told Reuters following Bloomberg's report of a U.S. criminal probe into its baby powder risk denials that any implication of a new development in the matter is "flatly wrong." Reference Link

  • 16

    Jul

  • 09

    Sep

  • 16

    Sep

JNJ Johnson & Johnson
$134.00

-6.09 (-4.35%)

07/11/19
RAJA
07/11/19
NO CHANGE
RAJA
Death of drug rebate rule a win for PBMs and distributors, says Raymond James
After multiple media outlets, including Politico, reported that the Trump Administration has decided to withdraw the drug rebate rule, Raymond James analyst Chris Meekins called the news "a win" for pharmacy benefit managers and drug distributors and "a slight negative" for the pharmaceutical makers. The cost of the proposal to the government was ultimately too high with little guarantee that list prices would go down, said Meekins. However, President Trump hinted something "major" on drug pricing was coming over the next week during his kidney care speech and the analyst thinks the President is planning to move forward with an executive order on pricing. Publicly traded pharmaceutical distributors include McKesson (MCK), Cardinal Health (CAH), Amerisource (ABC) and Patterson (PDCO). Owners of pharmacy benefit managers include CVS Health (CVS), UnitedHealth (UNH), Anthem (ANTM) and Cigna (CI). Publicly traded large cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/11/19
JEFF
07/11/19
NO CHANGE
Target $40
JEFF
Buy
Australia implants decision a 'big positive' for Establishment, says Jefferies
After Australia's Therapeutic Goods Administration proposed to cancel or suspend use of textured breast implants, concluding that these devices are associated with a higher rate of anaplastic large cell lymphoma, or ALCL, Jefferies analyst Raj Denhoy called the decision a "big positive" for Establishment Labs (ESTA). The decision is still in the proposal stage, but Establishment is the only manufacturer with products approved in Australia that is not on the list, which proposes to ban implants from Allergan (AGN), J&J's (JNJ) Mentor and other manufacturers, according to Denhoy. He keeps a Buy rating and $40 price target on shares of Establishment Labs.
07/12/19
FBCO
07/12/19
INITIATION
Target $156
FBCO
Outperform
Johnson & Johnson assumed with an Outperform at Credit Suisse
Credit Suisse analyst Matt Miksic assumed coverage of Johnson & Johnson with an Outperform rating and $156 price target. In a research note to investors, Miksic cites key drivers to the rating, including continued growth in Immunology, driven by Stelera and Tremfya, sustainable growth in Oncology driven by Imbruvica, Darzelex and Erleada, an "attractive" pipeline of filings in the 2019-2023 timeframe with greater than$1B potential each, and "stable" growth and cash flows in Medical Devices and Consumer.
07/12/19
WELS
07/12/19
NO CHANGE
Target $29
WELS
Outperform
Australia implant ban 'excellent news' for Establishment Labs, says Wells Fargo
Wells Fargo analyst David Maris believes Australia's proposal to ban, suspend or impose strict restrictions on a number of textured implants from Allergan (AGN), Johnson & Johnson (JNJ) and other smaller manufacturers is "excellent news" for Establishment Labs Holdings (ESTA). The move by Australia's regulatory body Therapeutic Goods Administration will help solidify Establishment's reputation for safety as the company's Motiva brand is the only listed company without any restricted brands, Maris tells investors in a research note. Further, Australia is a highly regulated and developed market, so the ban could help shift market share in other geographies outside of the county as well, contends the analyst. Maris reiterates an Outperform rating on Establishment Labs with a $29 priced target. The stock closed yesterday up $1.54 to $22.44.

TODAY'S FREE FLY STORIES

BKNG

Booking Holdings

$1,871.84

4.82 (0.26%)

11:23
07/18/19
07/18
11:23
07/18/19
11:23
Periodicals
Breaking Periodicals news story on Booking Holdings »

Hedgeye adds Booking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$123.46

-0.2 (-0.16%)

11:20
07/18/19
07/18
11:20
07/18/19
11:20
Options
Put buyer in Investment Grade Corporate Bond ETF »

Put buyer in Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULC

Fulcrum Therapeutics

$0.00

(0.00%)

11:18
07/18/19
07/18
11:18
07/18/19
11:18
Syndicate
Breaking Syndicate news story on Fulcrum Therapeutics »

Fulcrum Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
07/18/19
07/18
11:17
07/18/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
07/18/19
07/18
11:16
07/18/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
07/18/19
07/18
11:15
07/18/19
11:15
General news
Treasury announced a $113 B 3-pronged package of shorter coupons »

Treasury announced a $113…

11:15
07/18/19
07/18
11:15
07/18/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
07/18/19
07/18
11:15
07/18/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

XOP

SPDR Oil Exploration and Production Fund

$24.46

-0.15 (-0.61%)

11:10
07/18/19
07/18
11:10
07/18/19
11:10
Options
Size put rolldown in Oil and Gas Exploration ETF »

Size put rolldown in Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
5-Yr Note Announcement CUSIP Number data reported »

5-Yr Note Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
5-Yr Note Announcement Offering Amount data reported »

5-Yr Note Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
7-Yr Note Announcement CUSIP Number data reported »

7-Yr Note Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
2-Yr Note Announcement CUSIP Number data reported »

2-Yr Note Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
7-Yr Note Announcement Offering Amount data reported »

7-Yr Note Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
6-Month Bill Announcement Offering Amount data reported »

6-Month Bill Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
2-Yr Note Announcement Offering Amount data reported »

2-Yr Note Announcement…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
2-Yr FRN Note Announcement CUSIP Number data reported »

2-Yr FRN Note…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD is on…

11:10
07/18/19
07/18
11:10
07/18/19
11:10
General news
2-Yr FRN Note Announcement Offering Amount data reported »

2-Yr FRN Note…

11:09
07/18/19
07/18
11:09
07/18/19
11:09
General news
3-Month Bill Announcement Offering Amount data reported »

3-Month Bill Announcement…

YGTY

SSLJ.com

$1.36

0.1 (7.94%)

11:06
07/18/19
07/18
11:06
07/18/19
11:06
Hot Stocks
SSLJ.com announces resignation of auditor »

SSLJ.com Limited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBPH

Spring Bank Pharmaceuticals

$5.23

0.12 (2.35%)

11:05
07/18/19
07/18
11:05
07/18/19
11:05
Hot Stocks
Spring Bank reports agreement for HBV antisense oligonucleotide compounds »

Spring Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSRM

SSR Mining

$15.23

0.335 (2.25%)

11:05
07/18/19
07/18
11:05
07/18/19
11:05
Options
SSR Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

AMRB

American River

$12.92

(0.00%)

11:03
07/18/19
07/18
11:03
07/18/19
11:03
Hot Stocks
American River increases quarterly dividend to 7c per share from 5c »

American River Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

FULC

Fulcrum Therapeutics

$0.00

(0.00%)

11:02
07/18/19
07/18
11:02
07/18/19
11:02
Syndicate
Breaking Syndicate news story on Fulcrum Therapeutics »

Fulcrum Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.